Advertisement

The Effect of Preexisting Anticoagulation on Cerebrovascular Events in Left-Sided Infective Endocarditis

Published:September 05, 2019DOI:https://doi.org/10.1016/j.amjmed.2019.07.059

      Abstract

      Background

      Stroke is a frequent complication of infective endocarditis, especially infection involving left-sided valves. Management of anticoagulation in left-sided infective endocarditis is controversial as it is unclear whether anticoagulation impacts stroke and bleeding risk in patients with this condition. The objective of this study was to evaluate the effect of anticoagulation on stroke occurrence and bleeding complications in patients with left-sided infective endocarditis.

      Methods

      Patients admitted to a tertiary academic hospital with left-sided infective endocarditis between December 2011 and April 2018 were identified. Patients were stratified based on receipt of therapeutic anticoagulation prior to admission. The primary outcome measure was the rate of radiographically confirmed stroke at 10 weeks.

      Results

      Two-hundred and fifty-eight consecutive patients with left-sided infective endocarditis were identified. Patients receiving anticoagulation (n = 50) were older (median age 63 vs 52; P = .02), were more likely to have a history of atrial fibrillation (22% vs 8.2%; P < .01), more often had prosthetic valves (38% vs 13.9%; P < .01), and had a lower incidence of mitral valve involvement (40% vs 62%; P < .01), compared with patients not receiving anticoagulation. There was no significant difference in the rate of stroke, cerebrovascular hemorrhage, or mortality at 10 weeks between the two cohorts.

      Conclusions

      Preexisting anticoagulation did not appear to have an effect on stroke, cerebrovascular hemorrhage, or mortality in patients with left-sided infective endocarditis at 10 weeks. Continuation of anticoagulation in patients with a definitive preexisting indication should be considered in patients with left-sided infective endocarditis in the absence of other contraindications.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Murdoch DR
        • Corey GR
        • Hoen B
        • et al.
        Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study.
        Arch Intern Med. 2009; 169: 463-473
        • Wang A
        • Gaca JG
        • Chu VH
        Management considerations in infective endocarditis: a review.
        JAMA. 2018; 320: 72-83
        • García-Cabrera E
        • Fernández-Hidalgo N
        • Almirante B
        • et al.
        Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study.
        Circulation. 2013; 127: 2272-2284
        • Thuny F
        • Avierinos JF
        • Tribouilloy C
        • Giorgi R
        • Casalta JP
        • Milandre L
        • et al.
        Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study.
        Eur Heart J. 2007; 28: 1155-1161
        • Baddour LM
        • Wilson WR
        • Bayer AS
        • et al.
        Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association.
        Circulation. 2015; 132: 1435-1486
        • Habib G
        • Lancellotti P
        • Antunes MJ
        • et al.
        2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).
        Eur Heart J. 2015; 36: 3075-3128
        • Tornos P
        • Almirante B
        • Mirabet S
        • Permanyer G
        • Pahissa A
        • Soler-Soler J
        Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy.
        Arch Intern Med. 1999; 159: 473-475
        • Snygg-Martin U
        • Rasmussen RV
        • Hassager C
        • Bruun NE
        • Andersson R
        • Olaison L
        Warfarin therapy and incidence of cerebrovascular complications in left-sided native valve endocarditis.
        Eur J Clin Microbiol Infect Dis. 2011; 30: 151-157
        • Lee SJ
        • Oh SS
        • Lim DS
        • Hong SK
        • Choi RK
        • Park JS
        Usefulness of anticoagulant therapy in the prevention of embolic complications in patients with acute infective endocarditis.
        Biomed Res Int. 2014; 2014254187
        • Li JS
        • Sexton DJ
        • Mick N
        • et al.
        Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.
        Clin Infect Dis. 2000; 30: 633-638
        • Knaus WA
        • Draper EA
        • Wagner DP
        • Zimmerman JE
        Apache II: a severity of disease classification system.
        Crit Care Med. 1985; 13: 818-829
        • Paterson DL
        • Ko WC
        • Von Gottberg A
        • et al.
        International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections.
        Ann Intern Med. 2004; 140: 26-32
        • Charlson ME
        • Pompei P
        • Ales KL
        • MacKenzie CR
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        J Chronic Dis. 1987; 40: 373-383
        • Lyden P
        • Brott T
        • Tilley B
        • et al.
        Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.
        Stroke. 1994; 25: 2220-2226
        • Alagna L
        • Park LP
        • Nicholson BP
        • et al.
        Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis - Prospective Cohort Study.
        Clin Microbiol Infect. 2014; 20: 566-575
        • Salaun E
        • Touil A
        • Hubert S
        • et al.
        Intracranial haemorrhage in infective endocarditis.
        Arch Cardiovasc Dis. 2018; 111: 712-721
        • Yau JW
        • Lee P
        • Wilson A
        • Jenkins AJ
        Prosthetic valve endocarditis: What is the evidence for anticoagulant therapy?.
        Intern Med J. 2011; 41: 795-797
        • Dickerman SA
        • Abrutyn E
        • Barsic B
        • et al.
        The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS).
        Am Heart J. 2007; 154: 1086-1094
        • Colville T
        • Sharma V
        • Albouaini K
        Infective endocarditis in intravenous drug users: a review article.
        Postgrad Med J. 2016; 92: 105-111
        • Fonesca FA
        • Jones KM
        • Mendes DC
        • et al.
        The oral health of seniors in Brazil: addressing the consequences of a historic lack of public health dentistry in an unequal society.
        Gerodontology. 2015; 32: 18-27
        • Miro JM
        • Anguera I
        • Cabell CH
        • et al.
        Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database.
        Clin Infect Dis. 2005; 41: 507-514
        • Cabell CH
        • Pond KK
        • Peterson GE
        • et al.
        The risk of stroke and death in patients with aortic and mitral valve endocarditis.
        Am Heart J. 2001; 142: 75-80
        • Chu VH
        • Cabell CH
        • Abrutyn E
        • et al.
        Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database.
        Clin Infect Dis. 2004; 39: 1527-1530
        • Lalani T
        • Kanafani ZA
        • Chu VH
        • et al.
        Prosthetic valve endocarditis due to coagulase-negative staphylococci: Findings from the International Collaboration on Endocarditis Merged Database.
        Eur J Clin Microbiol Infect Dis. 2006; 25: 365-368
        • Fleischauer AT
        • Ruhl L
        • Rhea S
        • Barnes E
        Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence - North Carolina, 2010-2015.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 569-573